Skip to Main Content

Paper Details

Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit.
JCO Precis Oncol
7
2022
CD4, CD4+, CD8, CD8+, CD8+ T cells, CD8+, CD4 memory T cells, Immune cell populations, M1 macrophages, Metastatic Triple-Negative Breast Cancer, Patients, RNA, T cells, activated CD4+ memory T cells, circulating tumor, circulating tumor DNA, follicular helper, helper T cells, inflammatory gene, mTNBC, metastatic triple-negative breast cancer, patients, programmed cell death protein 1, programmed death-ligand 1, tumor, tyrosine, tyrosine kinase
Author NameAffiliation
Nancy U LinDana-Farber Cancer Institute
Nancy U LinDana-Farber Brigham Cancer Center
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenDana-Farber Cancer Institute
Eric P WinerDana-Farber Cancer Institute
Eric P WinerDana-Farber Brigham Cancer Center
Catherine J WuDana-Farber Cancer Institute
Nikhil WagleDana-Farber Cancer Institute
Nikhil WagleDana-Farber Brigham Cancer Center
Nikhil WagleDana-Farber Cancer Institute
Nikhil WagleDana-Farber Brigham Cancer Center
Sara M TolaneyDana-Farber Cancer Institute
Sara M TolaneyDana-Farber Brigham Cancer Center
  • 1 - 13

Datasets

Release 1.2